Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements
Obstetrics & Gynecology Science · 15.07.2026 · 69 (4) · 303-304
DOI: 10.5468/ogs.26134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.07.2026. Verfasst von Siyuan Zhu. Beteiligte Einrichtung: Department of Gynecology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. 858462770@qq.com. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gynecology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. 858462770@qq.com.
Zitieren
APA
Zhu, S. (2026). Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements. Obstetrics & Gynecology Science, 69(4), 303-304. https://doi.org/10.5468/ogs.26134
Vancouver
Zhu S. Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements. Obstetrics & Gynecology Science. 2026;69(4):303-304. doi:10.5468/ogs.26134
BibTeX
@article{Zhu2026,
author = {Zhu, Siyuan},
title = {Polymerase epsilon mutations in endometrial cancer: addressing heterogeneity, clinical applicability, and methodological refinements},
journal = {Obstetrics & Gynecology Science},
year = {2026},
volume = {69},
number = {4},
pages = {303--304},
doi = {10.5468/ogs.26134}
}
EUVIMED